CyPath® Lung unit sales increased 146% year-over-year in the first quarter of 2026, reflecting accelerating physician adoption and expanding clinical use of the Company’s noninvasive lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results